Together, these findings demonstrated that Arid1a deletion in combination with K‐ras mutation reprograms cancer cell metabolism and enhances fatty acid biosynthesis, suggesting a novel avenue for targeted therapy. This evidence concerns the gene ARID1A and cancer.